期刊文献+

血清乙型肝炎病毒前S1及前S2抗原与HBV-DNA的相关性研究 被引量:4

Correlative research between Pre-S1Ag,Pre-S2Ag and HBV-DNA in sera of patients with hepatitis B
原文传递
导出
摘要 目的:了解血清乙型肝炎病毒(HBV)前S1(Pre-S1)抗原与前S2(Pre-S2)抗原与HBV-DNA的相关性。方法:采用酶联免疫吸附法(ELISA)检测320例乙肝患者血清Pre-S1抗原与Pre-S2抗原,同时采用荧光定量PCR方法检测血清HBV-DNA水平。结果:199例HBV-DNA阳性的乙肝患者Pre-S1抗原和Pre-S2抗原的阳性率分别为82.9%和75.9%;121例HBV-DNA阴性的乙肝患者Pre-S1抗原和Pre-S2抗原的阳性率分别为35.5%和26.4%。HBV-DNA阴性组和HBV-DNA阳性组患者的Pre-S1抗原及Pre-S2抗原阳性率均差异有统计学意义(均P<0.01),且Pre-S1、Pre-S2抗原阳性率与HBV-DNA载量呈高度相关性。结论:Pre-S1与Pre-S2抗原是病毒感染和复制的指标,与HBV-DNA具有高度相关性,对临床标本进行HBV-DNA与Pre-S1、Pre-S2抗原联合检测,可弥补HBV-DNA检测的不足,对预防HBV复制和传播有重要价值。 Objective: To analyze the correlation between hepatitis B virus DNA(HBV-DNA) and Pre-S1 Pre-S2 of hepatitis B. Method:Serum Pre-S1 & Pre-S2 from 320 cases were detected by enzyme-linked immunosor- bent assay (ELISA),and HBV-DNA was detected by fluorescent quantitative PCR at the same time. Result: A- mong 199 cases of HBV-DNA positive patients,the positive rate of Pre-S1 and Pre-S2 were 82.90% and 75.9%,re- spectively. However,among 121 cases of HBV-DNA negative patients,the positive rate of Pre-S1 and Pre-S2 were 35.5 % and 26.4 % ,respectively. There were differences in the positive rate of Pre-S1 and Pre-S2 between HBV- DNA negative patients and HBV-DNA positive patients(P〈0. 01) ,and Pre-S1 and Pre-S2 were highly correlated to HBV-DNA load. Conclusion: Pre-S1 and Pre-S2, as the index to virus replication and infection, may be highly correlated to HBV-DNA load. Determination of HBV-DNA and Pre-S1 & Pre-S2 could make up the lack of HBV- DNA testing,and be of significant value in preventing HBV replication and transmission.
出处 《临床血液学杂志》 CAS 2014年第2期124-125,127,共3页 Journal of Clinical Hematology
关键词 乙型肝炎病毒 乙型肝炎前S1抗原 乙型肝炎前s2抗原 hepatitis B virus Pre-S1 Pre-S2
  • 相关文献

参考文献10

二级参考文献79

共引文献90

同被引文献37

  • 1黄卫民,张思烽,朱江华.Pre-S_1Ag检测与乙型肝炎的临床关系[J].广西医学,2004,26(12):1777-1779. 被引量:3
  • 2中华医学会肝病学分会、感染病学分会.慢性乙型肝炎防治指南[J].临床肝胆病杂志,2011,27(1):1-12.
  • 3邓乐,温志立,何金秋,等.乙型肝炎患者联合检测血清前S1、前S2抗原、E抗原的临床意义[J].健康研究,2014,34(2):144-145.
  • 4Nguyen V,Levy MT.anti-viral therapy for prevention of perinatal HBV transmission - extending therapy beyond birth and the risk of post- partum flare,authors' reply[J].Aliment Pharmaco] Ther, 2014,40(1):116.
  • 5Atkins M, Hunt CM, Brown N, et al. Clinical signili- cance of YMDD mutant hepatitis B virus in a large co- hort of lamivudine- treated hepatitis B patients ( ab- stract) [J]. Hepatology, 1998,28 : 319A.
  • 6Lok AS,Lai CL, Leung N,et al. Long- term safety of lamivudine treatment in patients with chronic hepa- titis B[J]. Gastroenterology. 2003,125 (6) : 1714 - 1722.
  • 7Yeung P, Wong DK, Lai CL, et al. Association of hepatitis B virus pre- S deletions with the develop- ment of hepatoeellular carcinoma in chronic hepatitis B[J]. J Infect Dis,2011,203(5) :646 - 54.
  • 8张秀梅,武天石.乙肝PreS1抗原及抗体检测在乙肝感染诊断中的应用[J].中国校医,2008,22(4):437-438. 被引量:3
  • 9张晓明,李康怡.乙肝病毒前S_1、S_2抗原检测在肝癌、肝硬化患者中的应用价值[J].辽宁医学杂志,2009,23(2):81-81. 被引量:2
  • 10邱黎霞,郭满盈,杨海燕.血清PreS1、PreS2抗原在乙肝诊断中的价值[J].实验与检验医学,2009,27(2):177-178. 被引量:5

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部